Abeona Therapeutics (ABEO) Profit After Tax (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Profit After Tax of -$17.2 million for Q1 2026, down 42.38% year-over-year from -$29.9 million in Q1 2025, and up 29.85% quarter-over-quarter from -$24.6 million in Q4 2025.
Abeona Therapeutics (ABEO) Profit After Tax (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Profit After Tax history runs 16 years deep, the most recent figure standing at -$17.2 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 42.38% year-over-year to -$17.2 million; the TTM figure through Mar 2026 stood at $66.7 million (up 250.71% YoY), while the FY2025 annual figure was $67.1 million, up 205.25% from the prior year.
- Profit After Tax for Q1 2026 stood at -$17.2 million, up from -$24.6 million in the prior quarter.
- The five-year high for Profit After Tax was $113.7 million in Q2 2025, with the low at -$31.6 million in Q1 2024.
- The 5-year median for Profit After Tax is -$11.8 million (2023), against an average of -$6.1 million.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax plunged 306.49% in 2023, then jumped 1434.8% in 2025.
- Abeona Therapeutics' Profit After Tax stood at -$7.2 million in 2022, then tumbled by 130.24% to -$16.6 million in 2023, then surged by 43.99% to -$9.3 million in 2024, then sank by 164.37% to -$24.6 million in 2025, then grew by 29.85% to -$17.2 million in 2026.
- Business Quant data shows ABEO's Profit After Tax at -$17.2 million in Q1 2026, -$24.6 million in Q4 2025, and -$5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | -20.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.25 Mn |
| Mar 31, 2026 | -17.23 Mn |
| Dec 31, 2025 | -24.57 Mn |
| Sep 30, 2025 | -5.16 Mn |
| Jun 30, 2025 | 113.67 Mn |
| Mar 31, 2025 | -12.10 Mn |
| Dec 31, 2024 | -9.29 Mn |
| Sep 30, 2024 | -30.27 Mn |
| Jun 30, 2024 | 7.41 Mn |
| Mar 31, 2024 | -31.58 Mn |
| Dec 31, 2023 | -16.59 Mn |
| Sep 30, 2023 | -11.84 Mn |
| Jun 30, 2023 | -16.65 Mn |
| Mar 31, 2023 | -9.11 Mn |
| Dec 31, 2022 | -7.21 Mn |
| Sep 30, 2022 | -6.44 Mn |
| Jun 30, 2022 | -4.10 Mn |
| Mar 31, 2022 | -22.04 Mn |
| Dec 31, 2021 | -46.70 Mn |
| Sep 30, 2021 | -7.04 Mn |